Â鶹´«Ã½

News — Experts from RWJBarnabas Health and Rutgers Cancer Institute, New Jersey’s only National Cancer Institute (NCI)-designated Comprehensive Cancer Center, recently published a review examining the challenges of diagnosing and treating leukemia and lymphoma during pregnancy. Rutgers Cancer Institute is a leader nationally and globally in these highly complex scenarios. Because these cancers may require chemotherapy, treatment decisions must carefully balance risks to both the mother and baby. The review underscores the need for a multidisciplinary approach involving oncologists, obstetricians, and maternal-fetal medicine specialists. It also explores the latest treatment strategies, including targeted therapies and immunotherapy, and provides expert recommendations on navigating these complex cases. Read the full review published in Seminars in Perinatology:

Authors of the review include and hematologist/oncologists in the at Rutgers Cancer Institute and RWJBarnabas Health; Neil D. Palmisiano, MD, MS, system leader for Leukemia at RWJBarnabas Health and deputy director of Phase I Therapeutics for Hematologic Malignancies at Rutgers Cancer Institute; and , deputy director for Clinical Services and chief physician officer, Rutgers Cancer Institute and theand oncology lead for RWJBarnabas Health Medical Group, and system director of Medical Oncology, .